BRPI0814115A2 - Composição farmacêutica compreendendo composto de 11-deóxi-prostaglandina e método para estabilizar o composto - Google Patents

Composição farmacêutica compreendendo composto de 11-deóxi-prostaglandina e método para estabilizar o composto

Info

Publication number
BRPI0814115A2
BRPI0814115A2 BRPI0814115-0A2A BRPI0814115A BRPI0814115A2 BR PI0814115 A2 BRPI0814115 A2 BR PI0814115A2 BR PI0814115 A BRPI0814115 A BR PI0814115A BR PI0814115 A2 BRPI0814115 A2 BR PI0814115A2
Authority
BR
Brazil
Prior art keywords
compound
dexy
prostaglandine
pharmaceutical composition
stabilize
Prior art date
Application number
BRPI0814115-0A2A
Other languages
English (en)
Inventor
Yasuhiro Harada
Junichi Kawasaki
Yoshie Nishimura
Ryuji Ueno
Original Assignee
R Tech Ueno Ltd
Sucampo Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R Tech Ueno Ltd, Sucampo Ag filed Critical R Tech Ueno Ltd
Publication of BRPI0814115A2 publication Critical patent/BRPI0814115A2/pt
Publication of BRPI0814115B1 publication Critical patent/BRPI0814115B1/pt
Publication of BRPI0814115B8 publication Critical patent/BRPI0814115B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
BRPI0814115A 2007-07-19 2008-07-16 composição farmacêutica compreendendo o composto 11-deóxi-prostaglandina e método para estabilizar o composto BRPI0814115B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US92994807P 2007-07-19 2007-07-19
US60/929,948 2007-07-19
PCT/JP2008/063222 WO2009011449A2 (en) 2007-07-19 2008-07-16 Pharmaceutical composition comprising 11-deoxy-prostaglandin compound and method for stabilizing the compound

Publications (3)

Publication Number Publication Date
BRPI0814115A2 true BRPI0814115A2 (pt) 2015-02-03
BRPI0814115B1 BRPI0814115B1 (pt) 2019-04-02
BRPI0814115B8 BRPI0814115B8 (pt) 2021-05-25

Family

ID=39720491

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0814115A BRPI0814115B8 (pt) 2007-07-19 2008-07-16 composição farmacêutica compreendendo o composto 11-deóxi-prostaglandina e método para estabilizar o composto

Country Status (14)

Country Link
US (2) US8969324B2 (pt)
EP (2) EP2178516B1 (pt)
JP (2) JP5390519B2 (pt)
KR (1) KR101485212B1 (pt)
CN (2) CN103393618A (pt)
AU (1) AU2008276840B2 (pt)
BR (1) BRPI0814115B8 (pt)
CA (1) CA2691995C (pt)
IL (1) IL203064B (pt)
MX (1) MX339727B (pt)
NZ (2) NZ583203A (pt)
RU (3) RU2506072C2 (pt)
TW (2) TWI446912B (pt)
WO (1) WO2009011449A2 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8026393B2 (en) 2006-01-24 2011-09-27 Sucampo Ag Soft-gelatin capsule formulation
EP2739278A4 (en) * 2011-08-05 2015-03-18 Sucampo Ag PROCESS FOR TREATING SCHIZOPHRENIA
WO2014159679A1 (en) 2013-03-12 2014-10-02 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Methods for using lubiprostone to absorb fluid from the subretinal space
JP6580414B2 (ja) * 2015-08-07 2019-09-25 小林製薬株式会社 生薬末含有錠剤
US10716544B2 (en) 2015-10-08 2020-07-21 Zmk Medical Technologies Inc. System for 3D multi-parametric ultrasound imaging
CN108619107A (zh) * 2018-05-28 2018-10-09 青海制药厂有限公司 一种含鲁比前列酮的软胶囊及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU36479A1 (pt) * 1958-02-12
JPS5350141A (en) * 1976-10-18 1978-05-08 Ono Pharmaceut Co Ltd Stabilization of prostaglandin and prostaglandin analogues
US4310543A (en) * 1980-10-09 1982-01-12 Hoffmann-La Roche Inc. Prostaglandin compositions
US4301175A (en) * 1980-12-29 1981-11-17 The Upjohn Company E-Type prostaglandin compositions
US4431833A (en) * 1982-12-27 1984-02-14 American Cyanamid Company Prostaglandin and hydroxylated fatty acid ester formulations
KR920007569B1 (ko) * 1984-11-30 1992-09-07 쥬우가이 세이야꾸 가부시끼가이샤 프로스타글란딘 e 유도체의 안정한 제제의 제조방법
US5166174A (en) * 1987-01-28 1992-11-24 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti-ulcers containing same
US6183466B1 (en) * 1998-08-21 2001-02-06 Alza Corporation Dosage form comprising a capsule
CN1268623C (zh) * 1999-10-15 2006-08-09 苏坎波公司 组合物和使该组合物稳定的方法
DE60319355T3 (de) * 2002-04-25 2012-01-05 Banner Pharmacaps Inc. Kaubare weichkapsel
FR2850275B1 (fr) * 2003-01-24 2005-04-08 Scherer Technologies Inc R P Capsules molles a macher contenant une substance active a gout masque
JP2007523904A (ja) * 2004-02-17 2007-08-23 シムライズ・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング・ウント・コンパニー・コマンジツト・ゲゼルシヤフト 被覆された、球状のシームレス型充填カプセル
AR055846A1 (es) * 2005-01-27 2007-09-12 Sucampo Ag Compuesto de prostaglandina y metodo para tratar trastornos del sistema nervioso central
KR20160120809A (ko) * 2005-03-04 2016-10-18 수캄포 아게 말초 혈관 질환 치료를 위한 방법 및 조성물
US8026393B2 (en) 2006-01-24 2011-09-27 Sucampo Ag Soft-gelatin capsule formulation

Also Published As

Publication number Publication date
MX339727B (es) 2016-06-06
CN101808623A (zh) 2010-08-18
US20150126609A1 (en) 2015-05-07
NZ595270A (en) 2013-04-26
RU2010105847A (ru) 2011-08-27
EP2327398A2 (en) 2011-06-01
US8969324B2 (en) 2015-03-03
RU2018113296A (ru) 2019-10-14
WO2009011449A2 (en) 2009-01-22
CA2691995A1 (en) 2009-01-22
AU2008276840B2 (en) 2013-10-03
EP2178516A2 (en) 2010-04-28
RU2506072C2 (ru) 2014-02-10
IL203064B (en) 2018-02-28
KR20100053563A (ko) 2010-05-20
BRPI0814115B1 (pt) 2019-04-02
TWI552772B (zh) 2016-10-11
BRPI0814115B8 (pt) 2021-05-25
US20090022787A1 (en) 2009-01-22
WO2009011449A3 (en) 2010-04-29
JP5390519B2 (ja) 2014-01-15
KR101485212B1 (ko) 2015-01-22
CA2691995C (en) 2016-04-26
MX2010000693A (es) 2010-06-01
AU2008276840A1 (en) 2009-01-22
TW200911273A (en) 2009-03-16
RU2013135403A (ru) 2015-02-10
TWI446912B (zh) 2014-08-01
TW201436824A (zh) 2014-10-01
JP2010533707A (ja) 2010-10-28
NZ583203A (en) 2011-10-28
CN101808623B (zh) 2013-08-14
EP2178516B1 (en) 2015-09-09
EP2327398A3 (en) 2014-05-21
CN103393618A (zh) 2013-11-20
JP2014001247A (ja) 2014-01-09
RU2651471C2 (ru) 2018-04-19
US9254326B2 (en) 2016-02-09

Similar Documents

Publication Publication Date Title
LTPA2018005I1 (lt) Farmacinė kompozicija
LTPA2018014I1 (lt) Farmacinė kompozicija 514
BRPI0906962A2 (pt) Composto, e, composição farmacêutica
BRPI0906556A2 (pt) Composto, e, composição farmacêutica
BRPI0819218A2 (pt) Métodos, estojos e composições para administração de compostos farmacêuticos
BRPI0721651A2 (pt) Composição farmacêutica
BRPI0919466A2 (pt) composição farmacêutica para liberação modificada
BRPI0815407A2 (pt) Composições e métodos para controlar nematódeos
BRPI0918971A2 (pt) tienopirimidinas para composições farmacêuticas
BRPI0715712A2 (pt) Composição farmacêutica
BRPI0719393A2 (pt) Composição farmacêutica
BRPI0911685A2 (pt) composto, método para o tratamento de uma doença, uso de um composto, composição farmacêutica, e, kit
DK2120884T3 (da) Farmaceutisk sammensætning
BRPI0917681A2 (pt) Composto, e, composição farmacêutica
BRPI0716445A2 (pt) composiÇço farmacÊutica
BRPI0809661A2 (pt) Composição farmacêutica estabilizada contendo pregabalina
BRPI0720234A2 (pt) Composição farmacêutica
BRPI0819232A2 (pt) composto heterocíclico e composição farmacêutica do mesmo
DK2285413T3 (da) Farmaceutisk sammensætning
BRPI0814821A2 (pt) Composto, composição farmacêutica, e, processo para preparar um composto
BRPI0909885A2 (pt) composição decorativa e método para sua utilização
BRPI0921313A2 (pt) composição farmaucêutica
BRPI0814043A2 (pt) composição farmacêutica para aplicação tópica de compostos pouco solúveis
BRPI0907706A2 (pt) Composto, uso do dito composto e composição farmacéutica compreendendo o dito composto
DE602008005137D1 (de) Chinolonverbindung und pharmazeutische zusammensetzung

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06I Publication of requirement cancelled [chapter 6.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2467 DE 17/04/2018 POR TER SIDO INDEVIDA.

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 02/04/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 02/04/2019, OBSERVADAS AS CONDICOES LEGAIS

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 16/07/2008 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF